Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)
Articolo
Data di Pubblicazione:
2008
Citazione:
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13) / A. Tripodi, F. Peyvandi, V. Chantarangkul, R. Palla, A. Afrasiabi, M.T. Canciani, D.W. Chung, S. Ferrari, Y. Fujimura, M. Karimi, K. Kokame, J.A. Kremer Hovinga, B. Laemmle, S.F. de Meyer, B. Plaimauer, K. Vanhoorelbeke, K. Varadi, P.M. Mannucci. - In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. - ISSN 1538-7933. - 6:9(2008 Sep), pp. 1534-1541. [10.1111/j.1538-7836.2008.03099.x]
Abstract:
BACKGROUND: Over the last 4 years ADAMTS-13 measurement underwent dramatic progress with newer and simpler methods.
AIMS: Blind evaluation of newer methods for their performance characteristics.
DESIGN: The literature was searched for new methods and the authors invited to join the evaluation. Participants were provided with a set of 60 coded frozen plasmas that were prepared centrally by dilutions of one ADAMTS-13-deficient plasma (arbitrarily set at 0%) into one normal-pooled plasma (set at 100%). There were six different test plasmas ranging from 100% to 0%. Each plasma was tested 'blind' 10 times by each method and results expressed as percentage vs. the local and the common standard provided by the organizer.
RESULTS: There were eight functional and three antigen assays. Linearity of observed-vs.-expected ADAMTS-13 levels assessed as r2 ranged from 0.931 to 0.998. Between-run reproducibility expressed as the (mean) CV for repeated measurements was below 10% for three methods, 10-15% for five methods and up to 20% for the remaining three. F-values (analysis of variance) calculated to assess the capacity to distinguish between ADAMTS-13 levels (the higher the F-value, the better the capacity) ranged from 3965 to 137. Between-method variability (CV) amounted to 24.8% when calculated vs. the local and to 20.5% when calculated vs. the common standard. Comparative analysis showed that functional assays employing modified von Willebrand factor peptides as substrate for ADAMTS-13 offer the best performance characteristics.
CONCLUSIONS: New assays for ADAMTS-13 have the potential to make the investigation/management of patients with thrombotic microangiopathies much easier than in the past
Tipologia IRIS:
01 - Articolo su periodico
Elenco autori:
A. Tripodi, F. Peyvandi, V. Chantarangkul, R. Palla, A. Afrasiabi, M.T. Canciani, D.W. Chung, S. Ferrari, Y. Fujimura, M. Karimi, K. Kokame, J.A. Kremer Hovinga, B. Laemmle, S.F. de Meyer, B. Plaimauer, K. Vanhoorelbeke, K. Varadi, P.M. Mannucci
Link alla scheda completa: